Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/microbion-selected-to-present-at-advanced-wound-care-summit-usa-302115810.html
https://www.prnewswire.com/news-releases/microbions-topical-pravibismane-phase-1b-moderate-or-severe-diabetic-foot-ulcer-infection-study-is-published-in-international-wound-journal-302107893.html
https://www.prnewswire.com/news-releases/microbions-pravibismane-granted-second-fda-orphan-drug-designation-for-the-treatment-of-non-tuberculous-mycobacterial-ntm-infections-302045880.html
https://www.prnewswire.com/news-releases/microbion-ceo-to-participate-in-panel-discussion-at-biofuture-2023-301948763.html
https://www.prnewswire.com/news-releases/microbion-presented-new-pravibismane-data-against-mycobacteroides-abscessus-at-the-6th-world-bronchiectasis-and-ntm-conference-301899119.html
https://www.prnewswire.com/news-releases/microbion-to-present-design-of-ongoing-phase-2-study-treating-diabetic-foot-ulcer-infections-at-the-2023-military-health-system-research-symposium-301899098.html
https://www.prnewswire.com/news-releases/microbion-corp-granted-us-patent-for-the-use-of-inhaled-pravibismane-for-pulmonary-infections-301788942.html
https://www.prnewswire.com/news-releases/microbion-corporation-initiates-phase-2-clinical-study-evaluating-topical-pravibismane-treatment-of-diabetic-foot-infections-301767435.html
https://www.prnewswire.com/news-releases/microbion-corporation-announces-poster-highlighting-pravibismane-activity-against-common-cystic-fibrosis-pulmonary-pathogens-to-be-presented-at-the-north-american-cystic-fibrosis-conference-2022-301667118.html
https://www.prnewswire.com/news-releases/microbion-corporation-announces-data-highlighting-pravibismanes-effect-on-bacterial-energetics-presented-at-asm-microbe-2022-301644052.html